Compound Detail
CHEMBL418270
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL418270 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | QOFWWNRCEIPMLU-UHFFFAOYSA-N |
6
Targets
6
Activities
1
Assay Types
0
PK Parameters
9
Publications
0
Known Names
Molecular Properties
368.4
MW (Da)
3.93
ALogP
6
HBA
2
HBD
92.7
PSA (Ų)
0.55
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 6 meas. best 6.82
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Tyrosine-protein kinase ABL1 CHEMBL1862 | IC50 | 6.82 | 6.82 | 150.0 | 1 |
| Bcr/Abl fusion protein CHEMBL2096618 | IC50 | 6.82 | 6.82 | 151.4 | 1 |
| Protein kinase C alpha type CHEMBL299 | IC50 | 5.77 | 5.77 | 1700.0 | 1 |
| Proto-oncogene tyrosine-protein kinase Src CHEMBL267 | IC50 | 5.05 | 5.05 | 9000.0 | 1 |
| Protein kinase C delta type CHEMBL2996 | IC50 | 4.77 | 4.77 | 17000.0 | 1 |
| Platelet-derived growth factor receptor CHEMBL2095189 | IC50 | 4.3 | 4.3 | 50000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Tyrosine-protein kinase ABL1 | IC50 | = | 150.0 | nM | 6.82 | Inhibition of v-Abl tyrosine kinase. | - |
| Bcr/Abl fusion protein | IC50 | = | 151.36 | nM | 6.82 | Inhibition of BCR-ABL kinase (unknown origin) | 23473682 |
| Protein kinase C alpha type | IC50 | = | 1700.0 | nM | 5.77 | Inhibition of protein kinase C alpha. | - |
| Proto-oncogene tyrosine-protein kinase Src | IC50 | = | 9000.0 | nM | 5.05 | Inhibition of c-Src-tyrosine kinase. | - |
| Protein kinase C delta type | IC50 | = | 17000.0 | nM | 4.77 | Inhibition of protein kinase C delta. | - |
| Platelet-derived growth factor receptor | IC50 | = | 50000.0 | nM | 4.3 | Inhibition of the platelet-derived growth factor receptor. | - |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.1016/S0960-894X(96)00601-4 | Tyrosine-protein kinase ABL1 | 1 |
| - | 10.1016/S0960-894X(96)00601-4 | Epidermal growth factor receptor | 1 |
| - | 10.1016/S0960-894X(96)00601-4 | Proto-oncogene tyrosine-protein kinase Src | 1 |
| - | 10.1016/S0960-894X(96)00601-4 | Platelet-derived growth factor receptor | 1 |
| - | 10.1016/S0960-894X(96)00601-4 | cAMP-dependent protein kinase (PKA) | 1 |
| - | 10.1016/S0960-894X(96)00601-4 | Protein kinase C alpha type | 1 |
| - | 10.1016/S0960-894X(96)00601-4 | Protein kinase C delta type | 1 |
| - | 10.1016/S0960-894X(96)00601-4 | No relevant target | 1 |
| 23473682 | 10.1016/j.bmcl.2013.01.113 | Bcr/Abl fusion protein | 1 |
Data from ChEMBL 36 via Core Engine